ABNORMALITIES IN P53 AND DNA CONTENT IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER

被引:15
作者
MELLON, K
WILKINSON, S
VICKERS, J
ROBINSON, MC
SHENTON, BK
NEAL, DE
机构
[1] UNIV NEWCASTLE UPON TYNE,FREEMAN HOSP,DEPT UROL,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,FREEMAN HOSP,DEPT PATHOL,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND
来源
BRITISH JOURNAL OF UROLOGY | 1994年 / 73卷 / 05期
关键词
P53; TUMOR SUPPRESSOR GENE; DNA; PLOIDY; BLADDER CANCER;
D O I
10.1111/j.1464-410X.1994.tb07637.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if transitional cell tumours of the bladder which contain mutations in the p53 gene have alterations in their DNA content. Materials and methods In 33 transitional cell tumours of the bladder, DNA content was determined by now cytometry and compared with expression of mutant p53 as assessed by immuno-histochemistry. Results Abnormal DNA content was associated with increased staining for p53 (P < 0.05), high tumour stage (P < 0.001) and increased histological grade (P < 0.01). Although positive staining for p53 was frequently associated with abnormal DNA content, a significant number of non-diploid tumours stained negatively for mutant p53. Conclusion These data demonstrate that increased staining for p53 is associated with abnormalities in DNA content suggesting that mutation of the p53 gene is associated with an increased rate of chromesomal abnormalities and an increased rate of cell proliferation.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 17 条
[1]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[2]   WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO [J].
FARMER, G ;
BARGONETTI, J ;
ZHU, H ;
FRIEDMAN, P ;
PRYWES, R ;
PRIVES, C .
NATURE, 1992, 358 (6381) :83-86
[3]   ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].
GANNON, JV ;
GREAVES, R ;
IGGO, R ;
LANE, DP .
EMBO JOURNAL, 1990, 9 (05) :1595-1602
[4]   FLOW-CYTOMETRY USING PARAFFIN-EMBEDDED TISSUE - 5 YEARS ON [J].
HEDLEY, DW .
CYTOMETRY, 1989, 10 (03) :229-241
[5]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[6]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[7]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456
[8]   OVER-EXPRESSION OF P53 NUCLEAR ONCOPROTEIN IN TRANSITIONAL-CELL BLADDER-CANCER AND ITS PROGNOSTIC VALUE [J].
LIPPONEN, PK .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :365-370
[9]   P53, C-ERBB-2 AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE BENIGN AND MALIGNANT PROSTATE [J].
MELLON, K ;
THOMPSON, S ;
CHARLTON, RG ;
MARSH, C ;
ROBINSON, M ;
LANE, DP ;
HARRIS, AL ;
HORNE, CHW ;
NEAL, DE .
JOURNAL OF UROLOGY, 1992, 147 (02) :496-499
[10]   AMPLIFICATION OF A GENE ENCODING A P53-ASSOCIATED PROTEIN IN HUMAN SARCOMAS [J].
OLINER, JD ;
KINZLER, KW ;
MELTZER, PS ;
GEORGE, DL ;
VOGELSTEIN, B .
NATURE, 1992, 358 (6381) :80-83